European Strategy Forum on Research Infrastructures

Slides:



Advertisements
Similar presentations
A 2030 framework for climate and energy policies Marten Westrup
Advertisements

29/08/2003 Work Package 1 Network Management R. Wick – Senior Project Manager.
16/06/2004 EuroPa Plenary Meeting -Paris EuroPa Plenary Meeting Paris Agenda EuroPa Plenary Meeting, Paris 9:00 - 9:15Meeting objectives /
ICT research priorities and recommendations for strategy development in the WBC Ulrike Kunze / PT-DLR, Germany Consultation session on recommendations.
WBC-INCO.NET WP3 – Report on opportunities to access S&T Infrastructures Davor Kozmus, MHEST Steering Platform Meeting 29. October 2009, Zagreb.
Strengthening the Strategic Cooperation between the EU and Western Balkan Region in the field of ICT Research Input to panel discussion: Concrete actions.
Research Leaders: Meeting the challenge Mark Walport 19 November 2008.
Story of an Essential Resolution The WHO Resolution on A Global Framework on Essential Health R&D.
Role and Strategic Use of MDTFs: the way forward UNDG – Donor Meeting New York, 24 June
Funding system for research Research Infrastructure
1 Commission Open Data Strategy & funding possibilities thematic networks Katarzyna Janicka-Pawlowska Legal officer, European Commission LAPSI Public.
Ministry of Health and Social Affairs Sweden The National Government Service Centre Sami Soliman Ministry of Health and Social Affairs, Division for Public.
Regional Policy EUROPEAN COMMISSION 1 EGTC regulation EGTC regulation ESF and EGTC regulations Regulation of the European Parliament and of the Council.
1 EU Strategy for the Baltic Sea Region Anders Lindholm European Commission DG Regional Policy, Territorial Cooperation.
The French National Alliance for Life Sciences and Health AVIESAN Prof. André Syrota Chairman and CEO of Inserm President of Aviesan STOA, Brussels, June.
EN Regional Policy EUROPEAN COMMISSION Information and Publicity SFIT, 15 June 2006 Barbara Piotrowska, DG REGIO
Distributed RI facilities Eeva Ikonen EU-US ENV RI session in Rome ( )
Research Infrastructures: Towards FP7 ENSCONET, second annual meeting Valencia, June 16, 2006 Jean-Emmanuel Faure, European Commission DG Research.
WELCOME TO OUR CHALLENGES! Where we would like to be...
Italian Participation in FP7 Programme Capacities Research Infrastructures Prof. Caterina Petrillo Italian Delegate to FP7 Capacities - Infrastructures.
Financial support for integrated rural development in the Nitra Self-governing Region Office of the Nitra Self-governing region Department of strategic.
GHS Implementation in Indonesia
Robert-Jan Smits Director, DG Research, European Commission Towards a European Strategy for Research Infrastructures Opportunities for the Arctic region.
UNICA EC PROJECTS. UNICA - EC PROJECTS PROJECTS Information Project on Higher Education Reform III: Lisbon Strategy and Bologna Process Tempus Joint European.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
1 Supporting the cooperation and coordination of research activities carried out at national or regional level The “ERA-NET” Scheme
1 RESEARCH INFRASTRUCTURES Synergy in using FP7 and SFs for the development of Research Infrastructures Warsaw, 13 February 2006 Hervé Pero, European Commission.
ELI – the international dimension Wolfgang Sandner Director General and CEO ELI Delivery Consortium International Association Prague, 24 May 2013 Project.
The ESFRI context. Clinical Trials as Instruments supporting Evidence-based Medical Practice. Dr Rafael de Andres Medina, Instituto de Salud Carlos III.
Flanders and ESFRI Marc LUWEL Hercules Foundation May 2014.
ECVAM Key Area Sensitisation: Overview on Activities Silvia Casati, Chantra Eskes.
Research Infrastructures The Research Infrastructures in FP7.
Η συμβολή των ομάδων εργασίας των Θεματικών Τομέων του ESFRI στον νέο Οδικό Χάρτη – Οι τρέχουσες εξελίξεις Στρατηγική για την Υγεία και τα Τρόφιμα Health.
Joint UNECE/Eurostat work session on statistical data confidentiality October 2013 Ottawa, Canada Improvement of access to European microdata Outcome.
EuroMarine Integration of European Marine Research Networks of Excellence General Assembly, Bremen (DE) January 18-19, 2012.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
The Preparatory Phase Proposal a first draft to be discussed.
1 Research Infrastructures in FP7 EUDET Annual Meeting 19 October 2006, Munich Dr. Gerburg Larsen European Commission, RTD-B.3 - Research Infrastructures.
1 Common Challenges Across Scientific Disciplines Laurence Field CERN 18 th November 2013.
1 DG RTD-B ERA: Research Programmes and Capacity Research Infrastructures Unit Maria Theofilatou FP7 Community actions Research Infrastructures of Social.
EPOS Preparatory phase Torild van Eck (ORFEUS) Call INFRA Deadline: December 3, 2009 Funding: between 3 and 6 MEuro Duration: max 4 year.
EPOS a long term integration plan of research infrastructures for solid Earth Science in Europe Preparatory Phase Project
FP7 Capacities Research Infrastructures (RI) in the field of Health Research Infrastructures (RI) in the field of Health Infrastructures NCPs: Radu TAMAIAN.
WP2 Legal, Governance & Ethical Issues Stakeholder Meeting in Heidelberg 30 January 2012 Co- Chairs Dr. Edvard Beem, ZonMW, NL Dr. Silke Schumacher, EMBL.
Notur: - Grant f.o.m is 16.5 Mkr (was 21.7 Mkr) - No guarantees that funding will increase in Same level of operations maintained.
1 Support for New Research Infrastructures in the EU 7 th Framework Programme for Research Elena Righi European Commission SKADS Workshop, Paris, 4 September.
ESTELA Summer Workshop, 26 June 2013 The EU-SOLARIS project.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
ERINHA: Framework for the biological high containment research infrastructure STOA – AVIESAN Workshop June 19th 2012, European Parliament, Brussels.
EGEE-III INFSO-RI Enabling Grids for E-sciencE EGEE08 conference, Istambul Life sciences cluster perspective on EGI V. Breton, CNRS On.
The Concept The format of BBMRI should be a distributed hub structure in which the hubs coordinate activities, including collection, exchange and analysis.
European Life Sciences Infrastructure for Biological Information ELIXIR’s needs from the EOSC Steven Newhouse, EMBL-EBI Part of the.
Community Actions for Research Infrastructures Oslo, October 2010 Anna Maria Johansson, DG RTD Research Infrastructures.
ERA-Instruments Thomas Gübitz, Johannes Janssen, Christian Renner, Bonn, 4 Februar 2008 Infrastructure Funding in the Life Sciences.
European Life Sciences Infrastructure for Biological Information European Life Sciences Infrastructure for Biological Information.
Project Summary Human biological samples including associated medical data, and biomolecular research tools are key resources in unravelling the interplay.
K. Zatloukal The European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI) Kurt Zatloukal, Medical University of Graz, Austria.
Professor John Womersley ESFRI Chair. ESFRI The European Strategy Forum on Research Infrastructures (ESFRI) was established in 2002 with a mandate from.
Launch event ICRI 2016, Cape Town - South Africa Launch event ICRI 2016 Cape Town South Africa David Bohmert Member ESFRI Executive Board Swiss ESFRI Delegate.
Go LNG LNG Value Chain for Clean Shipping, Green Ports and Blue Growth in Baltic Sea Region.
ACTRIS on the ESFRI Roadmap
ERIC Experiences and New Developments
Davor Kozmus, MHEST Steering Platform Meeting 29. October 2009, Zagreb
Use of National Strategies for the Development of Statistics
AMICI WP1 – Management, coordination and dissemination
CEITEC Nano Research Infrastructure
ACTRIS – EMEP, THE WAY FORWARD
ESFRI ROADMAP Madrid, 12th March 2019 Gonzalo Arévalo Nieto
Assembly of Members – 12 March 2019
Common Authentication and Authorisation Service for Life Science Research Mikael Linden, ELIXIR Finland.
Presentation transcript:

European Strategy Forum on Research Infrastructures

ESFRI roadmap Infrafrontier – animal disease models BBMRI – biobanking EATRIS – translational research ECRIN – clinical trials ELIXIR – bioinformatics Infrafrontier – animal disease models INSTRUCT – structural biology EU-OPENSCREEN – chemical biology BLS4 – high security labs Euro-BioImaging - bioimaging EMBRC – marine biology First First First roadmap roadmap roadmap 35 projects in 2006 in 2006 in 2006 Update in Dec 2008 + 10 projects

Grand Challenges - Understand genetic and environmental impact on human health - Develop novel strategies for diagnosis, prevention and therapies

Why mouse? Mouse genome fully sequenced 95% similarity of the genes of mice and men Easy to breed and handle in captivity Extensive toolbox for manipulating the mouse genome Child an mouse with the ‘piebald’ trait, a disorder of human development associated with the c-kit gene (Picture from Current Biology 2[3]:161) Current Biology

Mouse models achieve high impact Why mouse? Publications on ‘Mouse Models’ Mouse models achieve high impact

The challenge Shortage on capacities and access: Phenotyping (characterising mouse models) Mouse Clinics EUMODIC, Infrafrontier Archiving and Dissemination of mice and data Repositories EMMA, Infrafrontier

Required capacities Phenotyping Archiving and distribution 1500 p.a.

Infrafrontier: two main parts Phenomefrontier Archivefrontier Archivefrontier/EMMA Systemic Phenotyping Archiving / Distribution + emerging centres + emerging centres Access to phenotyping data and mouse models Access to phenotyping services, data and mouse models

Capacity building required!

Osteogenesis imperfecta A group of genetic bone disorders ... Noted People with OI Jazz pianist Michel Petrucciani Actor writer and ethicist Peter Radke... In the mouse model: Bisphosphonate treatment … reverses bone phenotype … but does not lower mortality

The German Mouse Clinic www.mouseclinic.de Nature Methods 2005, Nature Genetics 2005, Nature Genetics 2008, Cell 2009

Mouse model for Osteogenesis imperfecta - Mutation in collagen I Bone phenotype Mineralisation defect Bone deformity fractures Beaded ribs Reduced Bone mineral content & decreased bone mineral density Systemic Lung phenotype Heart phenotype Reduced fat mass & increased lean mass Metabolic alterations

Infrafrontier partners 12 European Countries + Canada Research Institutions + Funding Agencies

Infrafrontier partners

Smaller Project Large Project Infrastructure

Very large Project: International Mouse Phenotyping Consortium (IMPC)

Infrafrontier and IMPC Keep in mind: Infrafrontier is a BMS research infrastructure, NOT a single project Infrafrontier has a different and broader portfolio than IMPC (infrastructure for bottom-up and top-down projects) State of the art research infrastructures are highly dynamic entities

Infrafrontier preparatory phase Official start: 01 March 2008 36 months until: 28 February 2011 4.5 Mio € funding by the European Commission www.infrafrontier.eu

Infrafrontier implementation

Infrafrontier implementation

Access to mouse resources and data

Operation Costs ES Cell Distribution ? € per line User Fees 500 –700 € Mouse Archiving 3,500 – 4,400 € per line Mouse Distribution 1,100 – 2,100 € per line User Fees 1,100 – 1,700 € Cohort Breeding 23,000 – 30,000 € per line Phenotyping 15,000 – 20,000 € per line User Fees to be developed

New mouse clinics and EMMA nodes Established facilities New facilities

Integration of national & European funds Funding Strategy Integration of national & European funds National infrastructure funds European Projects National and Technology Development Operation Personnel Physical Infrastructure

Decentralised funding model European Commission MS Central Coordination MS MS MS MS MS MS = Member State

Governance Infrafrontier ERIC (Boards)

Governance Infrafrontier ERIC (Tasks)

More Information …. www.infrafrontier.eu

Resource Sharing Policy The Rome Agenda: “Funding organizations should … cover the costs of deposition of materials arising from projects as part of the project budget.” “Funding agencies should … ensure appropriate data-sharing plans at the outset of projects …”

More Information …. Helmholtz Zentrum München Coordinator: Prof. Dr. Martin Hrabé de Angelis hrabe@helmholtz-muenchen.de Project Office: Dr. Michael Raess Dr. Ana de Castro infrafrontier@helmholtz-muenchen.de Helmholtz Zentrum München Institute of Experimental Genetics Ingolstädter Landstrasse 1 85764 Neuherberg

Scope of Activities

Constructing Required Capacities EMMA Repository Initial Investment (100 mouse lines): ~ 6,600,000 € for Construction ~ 2,000,000 € for Equipment Adding capacities for 100 lines ~ 1,300,000 € Mouse Clinics Initial Investment (100 mouse lines): ~ 15,000,000 € for Construction ~ 5,000,000 € for Equipment Adding capacities for 100 lines ~ 6,500,000 €

Maintaining Capacities EMMA Repository Cryo-Archive (100 mouse lines): ~ 10,000 € per year Maintaining and Updating Equipment ~ 10% of Purchasing Price per year Mouse Clinics Maintaining and Updating Equipment ~ 20% of Purchasing Price per year

Infrafrontier project – key objectives Preparation to meet increasing demands for phenotyping and archiving – capacity building Developing a business plan based on a sustainable funding concept Identification of the most suitable legal form Providing a strategic plan for the construction phase Reaching a legal agreement between all partners

Key deliverables     WP2 – Strategy and Governance WP3 – Legal Work WP4 – Financial Work & Funding Implementation Preparatory Phase 2008 2009 2010 2011 Strategic Plan Draft Strategic Plan Update WP2   WP4 Finance  Business Plan WP3 Legal Work  Legal status MoU